Total planned funding: $396,828,679
Allocations
Countries/Regions
| Eswatini | $396,828,679 |
Organizational Types
| Private Contractor | $98,394,382 |
| Unknown | $75,533,079 |
| NGO | $71,255,885 |
| University | $64,630,611 |
| Own Agency | $48,249,503 |
| FBO | $13,230,009 |
| Host Country Government Agency | $12,294,827 |
| Multi-lateral Agency | $9,159,694 |
| Other USG Agency | $4,030,689 |
| Implementing Agency | $50,000 |
Program Areas
| Care | $120,681,066 |
| Treatment | $96,770,878 |
| Prevention | $75,576,811 |
| Governance and Systems | $45,008,423 |
| Testing | $30,331,506 |
| Management and Operations | $28,459,995 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $77,270,172 |
| HBHC: Care: Adult Care and Support | $48,948,992 |
| HKID: Care: Orphans and Vulnerable Children | $40,158,970 |
| HVCT: Testing: HIV Testing and Counseling | $30,331,506 |
| HVMS: Management and Operations | $28,459,995 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $28,194,980 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,519,808 |
| HVSI: Strategic Information | $21,881,760 |
| HVTB: Care: TB/HIV | $21,428,409 |
| OHSS: Health Systems Strengthening | $16,119,336 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,843,743 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,751,309 |
| HTXD: Treatment: ARV Drugs | $10,678,150 |
| PDCS: Care: Pediatric Care and Support | $10,144,695 |
| PDTX: Treatment: Pediatric Treatment | $8,822,556 |
| HLAB: Laboratory Infrastructure | $7,007,327 |
| HMBL: Biomedical Prevention: Blood Safety | $1,266,971 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$57,073,213
Countries/Regions
Columbia University:
$53,197,235
Countries/Regions
Pact, Inc.:
$45,374,638
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions